Related Articles
First Weekly Transdermal Patch Approved for Alzheimer’s Dementia: ADLARITY
On March 14, 2022: FDA has approved the first and only once-weekly transdermal patch for Alzheimer’s dementia: Adlarity (Donepezil). Psychiatry Education Forum Academy has summarized…
Asenapine: Transdermal vs Sublingual?
ASENAPINE: TRANSDERMAL VS SUBLINGUAL This post will summarize the key differences between the transdermal and sublingual formulation of asenapine in the following 10 minutes of…
Managing Clozapine Adverse Events
Clozapine was FDA-approved for treatment-refractory schizophrenia in 1989 and has remained the gold standard treatment since then for this indication. Clozapine has established efficacy in…
Journal Club #1: Update on Nonpsychotic Unipolar Depression Management
We begin PEFA Journal Club’s updated schedule with our first journal club discussion today: Journal Club #1: The Psychopharmacology Algorithm Project at the Harvard South…
PEFA Newsletter: May 2021
PSYCHIATRY EDUCATION FORUM ACADEMY’S NEWSLETTER MAY 2021 Here is the summary of topics posted in the month of May at Psychiatry Education Forum Academy. These…